![]() ![]() Price and PaymentĪ) The price of the products will be the price stated on the Web Site at the time we undertake your order. This email formulates the contract between us. ![]() OrderingĪ) You may order products from the Web Site by submitting a completed order form through our online shop.ī) We will confirm acceptance of your order by e-mail to the address you have given (whether or not it is received). Prices and availability is also subject to change without notice. Product DescriptionĪ) The depiction and specification of products in the Web Site is approximate and we retain the right to effect changes which do not essentially compromise the quality or operation of those products.ī) We may correct any error in the Web Site or withdraw any product from sale without incurring liability. However, we make no representation and give no undertaking of any kind in respect of the information.ī) We will not be held responsible for any loss (direct, indirect or consequential) which may evolve from dependence on the content contained in the Web Site or in respect of any error or omission. You may also contact us by telephone on: (+353) 9490 28830Ī) We have endeavoured to ensure that the information and data provided in the Web Site is accurate. Copying, replication or exploitation of the content of this Web Site for any commercial or other trade related operations is taken very seriously by LLR-G5 and may result in costly legal action. The data and information in the Web Site is copyright to LLR-G5 Limited and remains our intellectual property. ![]() "G5®" and the G5® Logo are registered trademarks of LLR-G5 Limited. All rights reserved.We take our legal responsibilities very seriously - please take your time to read through this section in detail. Further research as in the obtaining of such derivatives via synthesis and their in vivo testing to confirm their higher pharmacological potential is currently on the way.ĪDME/Tox Anti-allergic Anti-inflammatory/Antinociceptive Antidepressant Anxiolytic N-methylanthranilic acid esters.Ĭopyright © 2019 Elsevier Ltd. Overall the second modification (5-pentanoic acid, 5-pentanoic acid and 5-(2-anilino)pentanoic acid) of all three original molecules was the one that achieved highest score in molecular docking and a better combination of the other parameters. Derivatives of the three original molecules were proposed. Interestingly this compound presented the best in vivo profile in previous studies by the group. The compound IMA seems to be the best one when all the combined parameters are put together. This manuscript dealt with their assessment in six pharmacological targets to understanding anti-inflammatory, antinociceptive, anxiolytic, antidepressant and anti-allergic activities using docking molecular as well as their pharmacokinetics and toxicological parameters prediction. The in silico evaluation for the three previously synthesized compounds (Methyl (MMA), propyl (PMA) and isopropyl (IMA) N-methylanthranilate), MMA and IMA originally found in the leaf essential oil of Choisya ternata, provided a very good confirmation for the in vivo pharmacological results obtained with such compounds for a number of pharmacological targets. ![]()
0 Comments
Leave a Reply. |